N

NEOVACS SA

21 employees

Neovacs, a biotech company, develops several therapeutic vaccines for the treatment of AIDS, cancer and auto-immune and allergic diseases.

Investor insights

Sectors invested in

Medical2
Biotechnology Research1
Biotechnology1
Pharmaceutical1
Health Care1

Funding rounds participated in

$3.3M sweet spot round size

Most of their 2 investments are in rounds between $1.5M and $5M

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
active immunotherapies and therapeutic vaccine
Health Care
Therapeutics

Date founded

1993

Investments made

S

SIGNIA THERAPEUTICS raised $1.5M on October 20, 2021

Investors: NEOVACS SA

B

Bio Detection K9 raised $5M on September 27, 2021

Investors: NEOVACS SA

Funding rounds raised

Total raised

$18M

from 2 investors over 2 rounds

N

NEOVACS SA raised $1.2M on February 8, 2021

Investors: Alpha Blue Oceanocean

N

NEOVACS SA raised $18M on July 17, 2007

Investors: Truffle Capital

FAQ